ORGANOVO HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.91 USD | -4.21% |
|
-14.95% | -18.02% |
Chart calendar Organovo Holdings, Inc.
c9525425f636af.jXMoiBcV4f-bXcP4EOwU_dSpl-o0ylm03nzE07JIGnA.vzBM8Gd2hMjTLq_AWoQnlqaeyJl3qBfS7S-qv94kewbkBVHiXXmwvtkz-w~27a538669929ed05b94dc16712431687
Upcoming events on Organovo Holdings, Inc.
No events available
Past events on Organovo Holdings, Inc.
| 26/01/2024 23:00 | Crohn & Colitis Congress |
| 31/10/2023 16:00 | Annual General Meeting |
| 11/09/2023 15:00 | H.C. Wainwright Global Investment Conference |
| 12/10/2022 17:00 | Annual General Meeting |
| 12/09/2022 12:00 | H.C. Wainwright Global Investment Conference |
| 05/10/2021 17:00 | Annual General Meeting - Second Call |
| 14/09/2021 17:00 | Annual General Meeting |
| 08/03/2021 | H.C. Wainwright Global Life Science Conference |
| 15/09/2020 17:00 | Annual General Meeting |
| 18/08/2020 | Reverse Split: 1 of 20 |
| 07/04/2020 18:00 | Extraordinary Shareholders Meeting |
| 25/03/2020 | Extraordinary Shareholders Meeting - M&A Vote |
| 16/12/2019 13:30 | Tarveda Therapeutics Inc. and Organovo Holdings, Inc. Merger Call |
| 05/09/2019 17:00 | Annual General Meeting |
| 07/08/2019 | Q1 2020 Earnings Release |
| 18/06/2019 18:15 | Raymond James Life Sciences & MedTech Conference |
| 22/05/2019 22:00 | FY 2019 Earnings Call |
| 21/05/2019 | FY 2019 Earnings Release |
| 22/04/2019 | Alliance for Regenerative Medicine Cell & Gene Meeting |
| 07/02/2019 22:00 | Q3 2019 Earnings Call |
Annual results
| Fiscal Period | March | 2019 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,09 3,25 -4.98% | 0,00 | 0,08 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -27,3 -28,1 2.92% | 0,00 | 0,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,6 -27,0 1.36% | 0,00 | 0,00 |
|
Net income Million USD | Released Forecast Spread | -26,6 -27,0 1.35% | -17,3 | 0,00 |
|
EPS USD | Released Forecast Spread | -4,60 -4,80 4.17% | -1,98 | -1,74 |
| Announcement Date | 22/05/19 | 14/07/23 | - |
Quarterly results
| Fiscal Period | March | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,08 - | 0,01 0,08 -93.33% | 0,08 | 0,10 | 0,10 | 0,12 | 0,12 | |
|
EBIT Million USD | Released Forecast Spread | -4,12 -4,24 2.9% | -3,68 -4,08 9.83% | ||||||
|
Net income Million USD | Released Forecast Spread | -4,03 | -3,99 -3,76 -6.28% | -3,60 -3,60 -0.03% | |||||
|
EPS USD | Released Forecast Spread | -0,46 | -0,46 -0,43 -6.98% | -0,40 -0,41 2.44% | -0,42 | -0,38 | -0,36 | -0,36 | -0,31 |
| Announcement Date | 10/08/23 | 09/11/23 | 08/02/24 | - | - | - | - | - |
More events
Past sector events for Organovo Holdings, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ONVO Stock
- Calendar Organovo Holdings, Inc.
